Controlling Mattress Material Changes After Sample Approval

When you've approved a mattress sample, you've established a baseline for quality, performance, and compliance. If your supplier later proposes a material change – perhaps due to a shortage or a new component – it's crucial to treat this as a new approval decision, not a minor adjustment. The default position should always be to hold the proposed alternative until its impact on the finished mattress is fully documented and approved. This article outlines a recommended process for managing such changes, from documenting the proposed substitution to releasing a new, traceable revision.

Start with the approved construction

Before considering any proposed material change, you need a clear, documented baseline of the currently approved mattress construction. Without this, it's impossible to accurately assess the impact of a substitution. If the approved baseline is not clearly identifiable, you should hold any proposed substitution. This applies whenever material or construction approval is being changed, unless a controlled approved alternative already covers this exact scope. Verification should involve checking your contract, controlled documents, and the named decision authority.

To establish this baseline, ensure you have:

• SKU and Size Scope: The specific mattress model and all affected sizes.
• Signed Specification: The detailed document outlining materials, dimensions, and construction.
• Bill of Materials (BOM) Revision: The exact version of the BOM that was approved with the sample.
• Approved Sample Identifier: A unique reference for the physical sample you signed off on.
• Relevant Test Reports: Any reports covering the approved construction, linked to the sample and BOM.

Sample acceptance, test coverage, and permission to release production are distinct steps. Accepting a sample confirms its initial suitability, but it doesn't automatically grant permission for future material variations. ISO guidance on quality management systems (QMS) identifies the need for records of production-change review results, authorising persons, and resulting actions. It also highlights the importance of release records that cover acceptance criteria and traceability to the person authorising delivery, along with traceability records where required, and records of nonconformity, actions, and concessions.

Record exactly what the supplier wants to change

The first step in evaluating a material substitution is to get a precise, auditable record of the proposed change. This goes beyond a simple "equivalent material" claim and requires a detailed comparison of the old and new components.

When a supplier proposes a change, ensure you record:

• Request ID and Reason: A unique identifier for the change request and the clear reason for the substitution (e.g., supply chain issue, cost reduction).
• Old and New Material Details:
• Supplier codes and internal part numbers for both materials.
• Full composition or grade (e.g., specific foam type, fabric blend).
• Relevant dimensions (e.g., foam thickness, fabric weight).
• Key performance specifications (e.g., density, firmness, durability ratings).
• Affected Products:
• All mattress SKUs and sizes that will use the new material.
• Any specific orders or production runs impacted.
• Implementation Details:
• Proposed start date or first affected production lot.
• Current stock levels of the old material.
• Whether the change is temporary or permanent.
• Supplier Claims:
• Any claimed equivalence in performance.
• Proposed cost or schedule implications.

It's important to separate claimed equivalence from measured evidence. While a supplier might state a material is "equivalent," this needs to be verified through testing against your approved tolerances.

For example, AIYI can provide a controlled material-substitution comparison for an identified mattress SKU. This links the approved BOM revision, the proposed replacement material, measured performance differences, and affected sizes. For an illustrative engineering case, consider replacing a 30 mm conventional polyurethane comfort foam with an alternative supplier's foam of equivalent nominal density and firmness. While properties like foam thickness, density, 40% compression stress, compression set, tensile strength, and elongation at break might appear similar, final acceptance requires actual test reports, controlled test conditions, and comparison against buyer-approved tolerances.

For each affected size, we would verify finished height, mattress weight, firmness response, edge performance, and roll-pack recovery. At least one representative construction would undergo comparative comfort and durability testing, with additional size-specific verification where loading or structural differences require it.

AIYI would issue an Engineering Change Request (ECR) containing the original and proposed material specifications, supplier identification, test results, affected SKU/size matrix, and risk assessment. The proposed revision would remain blocked from mass production until sample evaluation, applicable review, buyer approval, and formal BOM revision release were completed. Existing inventory and new production would remain traceable by material lot and production batch.

Material substitution is not approved solely because density, thickness, or supplier specifications appear equivalent. Approval must demonstrate that the replacement preserves the buyer-approved finished-mattress performance, applicable scope, and production consistency. The final evidence package would include the signed BOM change record, before/after material test reports, affected-size matrix, sample inspection results, buyer approval, and dated production-release authorisation.

Assess the impact on safety and performance

A material change, even a seemingly minor one, can have significant implications for a mattress's safety and performance characteristics. You need to route the change to appropriate technical review to ensure all relevant claims and requirements are still met.

The default position is to review affected evidence before deciding whether testing can be carried forward. This applies when a changed material or construction intersects a tested feature or declared requirement. This position changes only if existing controlled approval explicitly includes the alternative with matching conditions. Verification requires checking the actual report, specimen details, laboratory interpretation, territory, and intended use.

Consider the potential impact on:

• Ignition Behaviour: Changes to cover fabric, quilting, or filling materials can alter how a mattress reacts to ignition sources.
• Dimensions and Stability: Different materials might affect finished mattress height, edge support, or overall structural integrity.
• Firmness and Comfort: Even small changes in foam density or spring wire gauge can noticeably alter the feel and support.
• Fatigue and Durability: The long-term performance under repeated loading, including resistance to sagging or material breakdown.
• Construction Integrity: How well the new material integrates with other components, affecting stitching, bonding, and overall build quality.

Treating a change to the cover, quilting, filling, or other construction features as a reason to review the scope of existing evidence is crucial, rather than assuming interchangeability. You must also confirm the destination market and intended use, distinguishing between current regulatory changes and historical laboratory summaries. For example, the official 2025 amendments to the UK Furniture and Furnishings (Fire) (Safety) Regulations took effect on 30 October 2025, including scope exclusions and removal of display-label requirements. Furthermore, the GB General Product Safety Regulations 2005 differ from EU Regulation 2023/988, which applies in Northern Ireland from 13 December 2024.

Check what the existing test reports actually cover

Can the old reports support the revised build? To bound the carry-over decision, you must compare the specimen construction and filling identities with the proposed Bill of Materials (BOM). Where coverage is uncertain, seek a documented laboratory scope assessment and identify any additional testing required.

When reviewing existing test reports, consider:

• Specimen Construction: Does the tested specimen exactly match the proposed new construction, including all layers, fabrics, and components? SATRA describes mattress ignition testing on a specimen replicating construction and surface features, including quilting and tape edges.
• Filling Identities: Are the specific filling materials (e.g., foam grades, fibre types) in the report identical to the proposed substitute? SATRA distinguishes tests for individual fillings from composite fillings and notes an additional individual-foam requirement within composites.
• Laboratory Scope: If there's any doubt about whether a report covers the new material, consult the testing laboratory for a formal assessment of the report's applicability.

Do not assume every change invalidates every report, nor that a matching trade name proves coverage. The exact current applicable route and changed-report coverage need laboratory confirmation.

Agree the checks before approving the substitute

Before you can approve a material substitution, you need to establish clear acceptance criteria and a verification plan. This ensures that any decision is based on objective evidence rather than subjective claims. The default position is to approve only the defined revised scope after required evidence and authority are complete. This applies when comparison and acceptance criteria are agreed and passed. This changes if missing evidence warrants a hold, or if failed requirements warrant rejection or redesign. Verification requires reviewing results, the laboratory scope decision, signatories, and commercial authority.

Before any testing begins, agree on:

• Revised Sample Identity: A unique identifier for the sample made with the new material.
• Test Methods and Conditioning: The specific standards and environmental conditions for all tests.
• Comparison Baseline: What the new sample will be measured against (e.g., the original approved sample, a defined specification range).
• Acceptance Criteria: The measurable thresholds or ranges that the new material must meet to be approved.

Focus on selecting only the checks that are genuinely affected by the material change. For example, if a foam layer is changed, you might focus on:

• Measured Firmness: How the new foam affects the overall mattress firmness, often measured before and after durability testing. SATRA describes EN 1957:2012 roller fatigue testing and hardness or firmness measurements before and after rolling. FIRA describes its mattress durability procedure as 30,000 cycles with 1,400 N, assessing hardness, firmness, and thickness change.
• Thickness Change: Any compression or loss of height after durability testing.
• Fatigue Performance: How the material withstands repeated loading without significant degradation. It's important to explain measured fatigue changes without equating test cycles directly to years of use, as real-world conditions vary.
• Construction Integrity: Inspect for defects such as broken springs, stitching failures, or displaced fillings, as described by SATRA during durability assessment.

There are three possible outcomes for a material change request:

1. Approve: The defined scope is approved after all evidence meets the agreed requirements.
2. Hold: The request is put on hold due to gaps in evidence, inconclusive results, or a need for further investigation.
3. Reject: The request is rejected because the new material fails to meet critical requirements.

Document all technical, quality, and brand authorisations as contractually agreed. Remember that commercial concessions cannot waive applicable safety obligations. OPSS states that manufacturers and importers need to demonstrate relevant safety compliance, including technical records, risk reduction, labelling, and safe-use instructions.

Release the new revision without losing traceability

Once a material change has been thoroughly reviewed, verified, and formally approved, the final step is to implement it in production while maintaining complete traceability. The default position is to release only identifiable lots made to the authorised revision. This applies when revision and verification records are complete. This changes if mixed or untraceable lots require containment and disposition first. Verification requires checking the first affected lot, old-stock status, production documents, and shipment authority.

To ensure a controlled release:

1. Issue a New BOM Revision: Create a new Bill of Materials revision that incorporates the approved material change. This revision must be linked to the original change request ID, all verification results, and the dated authorisation.
2. Define Effective First Lot: Clearly identify the first production lot that will use the new material. This is critical for traceability.
3. Update Internal Documents: Revise all affected purchase specifications, work instructions, incoming material inspection checks, and final inspection records.
4. Manage Old Stock: Identify any remaining old material, work in progress, and finished stock. Record its permitted use (e.g., for specific legacy orders), segregation from new material, or disposition (e.g., scrap, return).
5. Authorise Shipment Release: Link the first changed lot and subsequent shipments to the approved criteria and the role authorising the release. ISO guidance on QMS identifies release records covering acceptance criteria and traceability to the person authorising delivery, along with traceability records where required, and records of nonconformity, actions, and concessions.
6. Address Unauthorised Changes: If an unauthorised substitution is discovered, immediately contain all affected stock. Assess its conformity and record its disposition before any release. Do not backdate approval for non-compliant material.

By following these steps, you ensure that every mattress lot can be traced back to its approved material-change decision, maintaining quality and compliance throughout the product lifecycle.